A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/26 (2006.01) A61K 47/20 (2006.01) A61K 47/18 (2006.01) A61K 47/26 (2006.01) A61K 47/28 (2006.01)
Patent
CA 2312190
Methods and formulations are presented that provide for a) the oral absorption of GLP-1 peptides that bind surfactants; and b) long-term storage of formulations containing these peptides. For example, a GLP-1/DSS complex is administered orally instead of parenterally, which is much more convenient for, and facilitates compliance with diabetic patients and persons with other GLP-1 treated conditions.
La présente invention concerne des procédés et des formulations permettant: a) l'absorption par voie orale des peptides GLP-1 fixant les surfactants; et b) la longue conservation des formulations renfermant ces peptides. Par exemple, un complexe GLP-1/DSS est administré par voie orale et non pas par voie parentérale, car ce mode d'administration convient mieux aux diabétiques et aux personnes souffrant d'autres troubles traités par les GLP-1, et il facilite la conformité de ce traitement avec un autre.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Glp-1 formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glp-1 formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glp-1 formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1925039